MRI-defined sarcopenia predicts mortality in patients with chronic liver disease.
Lucian BeerNina BastatiAhmed Ba-SsalamahSarah Pötter-LangKatharina LampichlerYesim BicanDavid LauberJacqueline HodgeTeresa BinterKatharina PomejBenedikt SimbrunnerGeorg SemmlerMichael TraunerMattias MandorferThomas ReibergerPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
Sarcopenia can be easily evaluated by a short MRI exam without the need for contrast injection. Sarcopenia is a risk factor for mortality, especially in patients with cACLD.